CLX·The Clorox Company
CLX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $1.11 | - | - |
| Q4'26 | $1.65 | $1.66 | +0.9% |
| Q3'26 | $1.55 | $1.64 | +6.1% |
| Q2'26 | $1.57 | $1.39 | -11.5% |
| Q3'25 | $0.78 | $0.85 | +9.2% |
| Q2'25 | $2.21 | $2.87 | +29.7% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $1.9B | - | - |
| Q4'26 | $1.9B | $1.9B | +1.6% |
| Q3'26 | $1.7B | $1.7B | +0.1% |
| Q2'26 | $1.7B | $1.7B | +0.0% |
| Q3'25 | - | $1.4B | - |
| Q2'25 | - | $2.0B | - |
CLX|Monthly Returns
Market Data
CLX Stock Snapshot
- Market cap
- 10.42B
- P/E ratio
- 17.8
- Day range
- $83.05 – $85.36
- News sentiment
- 41/100 · Neutral
- Analyst target
- $100.76 (+20.8%)
- Consensus
- Hold · 28 analysts
Price action on CLX is defensive - rallies are being sold rather than extended. In Consumer Defensive, names this size usually take direction from sector flows before company-level news.
Reverse DCF
What growth is priced into CLX?
At today's price, The Clorox Company needs to grow free cash flow about -7.6% a year for the next 10 years to justify its valuation at a 6.43% cost of capital. Over its actual history it has compounded free cash flow at 2.6% a year, so the market is asking for 10.2 percentage points below its own delivered rate. On that basis CLX looks priced below what its own growth record supports.
- Implied FCF growth
- -7.6%
- Historical FCF CAGR
- 2.6%
- Growth gap
- -10.2 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 6.43%
- Beta
- 0.48
Behaviour On Record
What CLX's own history says about today's numbers
- Realized volatility (21d)
- 21.4% 59th pct
- Below its peak
- -65.2%
- vs 200-day average
- -19.0%
- Up days (1y)
- 45%
The Clorox Company is currently running 21.4% annualised volatility over the last 21 sessions. Measured against CLX's own 13 years of daily returns rather than a market-wide average, that is the 59th percentile — close to its own typical level, against a typical reading of 19.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
CLX is trading -65.2% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -19.9%, and the deepest was -40.1% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -19.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 2nd percentile — a narrower gap than it typically runs. Over the past year CLX closed higher on 45% of sessions, and it is currently 1 session into a falling streak.
On September specifically: over 13 years of records, CLX finished the month higher 5 of 13 times, with a median return of -4.4% and an average of -3.2%. Its strongest month historically has been June at +2.0% on average, its weakest September at -3.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: CLX has opened more than 2% away from the prior close in 52 of 3,268 sessions (1.6% of the time), with the largest gaps running +5.9% and -5.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, CLX moved an average of 4.4% in the session after earnings, closing higher 2 of those 3 times, with a median move of +5.0% and a largest of +5.8%.
All figures computed from 3,269 daily closes between 2013-09-19 and 2026-09-18, split-adjusted, recomputed daily. Percentiles are against CLX's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of CLX's sector?
The Clorox Company sits in the Consumer Staples sector, currently ranked 6th of 11 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #6 of 11
- Sector state
- Improving
- Sector rotation score
- 60
Analyst Rating Changes
Are analysts turning bullish or bearish on CLX?
Citigroup most recently reiterated its rating on The Clorox Company to Neutral on Sep 11, 2026 with a price target of $97 (from $100). Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.
- Latest action
- Citigroup — Neutral
- 90-day upgrades
- 0
- 90-day downgrades
- 1
- Net rating momentum
- -1
